Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, March 02, 2016
LabConnect, a global provider of central laboratory and support services for biopharmaceutical, medical device and contract research organizations, announced it has recently secured a $4 million investment from BroadOak Capital Partners, a life ...
read more
Wednesday, March 02, 2016
Xpertdoc Technologies Inc., a Microsoft Gold Partner and a document generation and customer communications solutions provider, has announced that Camargo Pharmaceutical Services has selected Xpertdoc’s CCM platform and Microsoft Dynamics CRM ...
read more
Eurofins Scientific has announced the opening of its new state-of-the-art manufacturing and services facility in Louisville, KY, in the US. The large, 65,800 ft2 (6,113 m2) facility functions as the Group’s central genomics laboratory in North ...
read more
Monday, February 29, 2016
AstraZeneca has entered into a licensing agreement with China Medical System Holdings Ltd (CMS) for the commercialization rights in China to its calcium channel blocker, Plendil (felodipine).
read more
Monday, February 29, 2016
On Wednesday, February 24th, the United States Senate confirmed the nomination of Robert Califf, M.D. to be Commissioner of Food and Drugs. Dr. Califf was sworn into office on February 25th.
read more
Monday, February 29, 2016
Valeant Pharmaceuticals has announced that J. Michael Pearson has returned as Valeant's chief executive officer following his recovery from severe pneumonia and other complications, effective immediately.
read more
Friday, February 26, 2016
ImageIQ, an Imaging Software and Contract Research Organization supporting preclinical research and clinical trials, have formally announced a memorandum of understanding with T3 Labs, an Atlanta-based provider of biomedical preclinical testing and ...
read more
Friday, February 26, 2016
Pharm-Olam International Ltd., a multi-national, full-service Clinical Research Solutions Organization to the biopharmaceutical and medical device industries, has been selected as the Contract Research Organization for Infinity Pharmaceuticals, Inc. ...
read more
Friday, February 26, 2016
inviCRO, LLC, and Molecular NeuroImaging, LLC, both providers of imaging service solutions and analysis for research and drug development, announced they will merge all activities to provide the most comprehensive set of imaging services across the ...
read more
Wednesday, February 24, 2016
Deceleration of the pharmaceutical patent cliff, combined with expectations of a patent 'slope' for biologics, will support innovative drug manufacturers' U.S. sales, according to the first report in Fitch Ratings' 'Navigating the Pharmaceutical ...
read more
Wednesday, February 24, 2016
Aptuit and Icagen have announced a strategic alliance to give drug discovery customers access to ion channel and transporter technologies and expert services.
read more
Wednesday, February 24, 2016
Recipharm AB has entered into an agreement to acquire Italian CDMO, Mitim Srl adding scale and capabilities to the group. Mitim is currently owned by a private Italian family and is specialized in the filling of injectable beta lactam products. It ...
read more
Wednesday, February 24, 2016
Teva Pharmaceutical Industries is embarking on a strategic enterprise-wide corporate identity program to build a global brand.
read more
Wednesday, February 24, 2016
Sanofi has announced that the license and development agreement between Sanofi and kaléo, formerly Intelliject Inc., the developer of Auvi-Q® (epinephrine injection, USP), will terminate later this year.
read more
Wednesday, February 24, 2016
Albumedix has announced new data that supports an exclusive agreement with ThioLogics, a UCL Business (UCLB) company, to commercialize the next generation of stable albumin drug conjugates.
read more